Cimeven (ganciclovir) lyophilisate for solution for infusions 500 mg. №1 vial

Description

The drug Cimeven is indicated for adults and adolescents ≥ 12 yEars and Nose for:

treatment of cytomegalovirus (CMV) infection in patients with immunodeficiency;
prevention of cytomegalovirus infection by preventive therapy in patients with drug-induced immunosuppression (for example, after organ transplantation or cancer chemotherapy).
Cymevene is also indicated for children from birth to:

prevention of cytomegalovirus infection by universal prevention in patients with drug-induced immunosuppression (for example, after organ transplantation or cancer chemotherapy).
Official recommendations regarding the appropriate use of antiviral agents should be followed.